Note: Ingredients listed on restricted chemical lists
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
59 - 61
EC/CAS
215-181-3/1310-58-3
Name of the chemical
potassium hydroxide
Concentration
39 - 41
General Information
Version
1.0
Revision date
2024-02-19
Product name
POTASSIUM HYDROXIDE 40% SOLUTION
Emergency telephone
91 22 6663 6663
Icons in SDS
Company Information
company name
LOBA CHEMIE PVT. LTD
e-mail address of the competent person responsible for the Safety Data Sheet
info@lobachemie.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H314
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Harmful if swallowed. Causes severe skin burns and eye damage.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07
Signal word
Danger
Contains
Potassium hydroxide
Hazard statements
H302 - Harmful if swallowed. H314 - Causes severe skin burns and eye damage.
Precautionary statements
P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P280 - Wear protective clothing, eye protection, face protection, protective gloves. P301+P330+P331 - IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water . P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Nordic countries regulation Denmark MAL code : 00-3 (Executive Order No. 301 from 1993)
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %